vs
Aquestive Therapeutics, Inc.（AQST）与Rent the Runway, Inc.（RENT）财务数据对比。点击上方公司名可切换其他公司
Aquestive Therapeutics, Inc.的季度营收约是Rent the Runway, Inc.的1.2倍（$13.0M vs $10.6M），Rent the Runway, Inc.净利率更高（721.7% vs -244.8%，领先966.5%），Rent the Runway, Inc.同比增速更快（10.4% vs 9.7%），过去两年Aquestive Therapeutics, Inc.的营收复合增速更高（3.9% vs 1.0%）
Aquestive Therapeutics是一家特种制药企业，专注于中枢神经系统疾病创新疗法的开发与商业化。公司依托专有的药物递送技术打造便于患者使用的治疗方案，服务北美、欧洲市场的医疗机构与患者，核心管线覆盖神经学与精神病学领域的未满足医疗需求。
Rent the Runway Inc.是总部位于纽约的美国电商平台，由珍妮弗·海曼与珍妮弗·弗莱斯于2009年11月创立，主打设计师品牌服饰与配饰的租赁、订阅以及购买服务，是设计师服饰共享租赁模式的开创平台之一。
AQST vs RENT — 直观对比
营收规模更大
AQST
是对方的1.2倍
$10.6M
营收增速更快
RENT
高出0.7%
9.7%
净利率更高
RENT
高出966.5%
-244.8%
两年增速更快
AQST
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.0M | $10.6M |
| 净利润 | $-31.9M | $76.5M |
| 毛利率 | 55.2% | -126.4% |
| 营业利润率 | -221.6% | -152.8% |
| 净利率 | -244.8% | 721.7% |
| 营收同比 | 9.7% | 10.4% |
| 净利润同比 | -86.8% | 504.8% |
| 每股收益（稀释后） | $-0.26 | $13.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AQSTRENT
| Q4 25 | $13.0M | $10.6M | ||
| Q3 25 | $12.8M | $11.7M | ||
| Q2 25 | $10.0M | $7.6M | ||
| Q1 25 | $8.7M | $11.8M | ||
| Q4 24 | $11.9M | $9.6M | ||
| Q3 24 | $13.5M | $10.4M | ||
| Q2 24 | $20.1M | $8.9M | ||
| Q1 24 | $12.1M | $10.4M |
净利润AQSTRENT
| Q4 25 | $-31.9M | $76.5M | ||
| Q3 25 | $-15.4M | $-26.4M | ||
| Q2 25 | $-13.5M | $-26.1M | ||
| Q1 25 | $-22.9M | $-13.4M | ||
| Q4 24 | $-17.1M | $-18.9M | ||
| Q3 24 | $-11.5M | $-15.6M | ||
| Q2 24 | $-2.7M | $-22.0M | ||
| Q1 24 | $-12.8M | $-24.8M |
毛利率AQSTRENT
| Q4 25 | 55.2% | -126.4% | ||
| Q3 25 | 64.8% | -92.3% | ||
| Q2 25 | 54.4% | -168.4% | ||
| Q1 25 | 58.1% | -71.2% | ||
| Q4 24 | 61.9% | -122.9% | ||
| Q3 24 | 67.2% | -98.1% | ||
| Q2 24 | 77.5% | -131.5% | ||
| Q1 24 | 63.6% | -93.3% |
营业利润率AQSTRENT
| Q4 25 | -221.6% | -152.8% | ||
| Q3 25 | -89.6% | -171.8% | ||
| Q2 25 | -113.6% | -259.2% | ||
| Q1 25 | -222.1% | -65.3% | ||
| Q4 24 | -114.4% | -142.7% | ||
| Q3 24 | -61.2% | -92.3% | ||
| Q2 24 | 0.3% | -185.4% | ||
| Q1 24 | -74.3% | -185.6% |
净利率AQSTRENT
| Q4 25 | -244.8% | 721.7% | ||
| Q3 25 | -120.6% | -225.6% | ||
| Q2 25 | -135.4% | -343.4% | ||
| Q1 25 | -263.0% | -113.6% | ||
| Q4 24 | -143.7% | -196.9% | ||
| Q3 24 | -85.0% | -150.0% | ||
| Q2 24 | -13.7% | -247.2% | ||
| Q1 24 | -106.4% | -238.5% |
每股收益（稀释后）AQSTRENT
| Q4 25 | $-0.26 | $13.65 | ||
| Q3 25 | $-0.14 | $-6.55 | ||
| Q2 25 | $-0.14 | $-6.58 | ||
| Q1 25 | $-0.24 | $-2.72 | ||
| Q4 24 | $-0.18 | $-4.70 | ||
| Q3 24 | $-0.13 | $-4.17 | ||
| Q2 24 | $-0.03 | $-6.03 | ||
| Q1 24 | $-0.17 | $-5.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $50.7M |
| 总债务越低越好 | $27.5M | — |
| 股东权益账面价值 | $-33.7M | $-35.1M |
| 总资产 | $160.4M | $231.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AQSTRENT
| Q4 25 | — | $50.7M | ||
| Q3 25 | $129.1M | $43.6M | ||
| Q2 25 | $60.5M | $70.4M | ||
| Q1 25 | $68.7M | $77.4M | ||
| Q4 24 | $71.5M | $74.1M | ||
| Q3 24 | $77.9M | $76.6M | ||
| Q2 24 | $89.9M | $82.0M | ||
| Q1 24 | $95.2M | $84.0M |
总债务AQSTRENT
| Q4 25 | $27.5M | — | ||
| Q3 25 | $45.0M | — | ||
| Q2 25 | $45.0M | $340.6M | ||
| Q1 25 | $45.0M | $333.7M | ||
| Q4 24 | $32.5M | — | ||
| Q3 24 | $45.0M | — | ||
| Q2 24 | $45.0M | — | ||
| Q1 24 | $45.0M | — |
股东权益AQSTRENT
| Q4 25 | $-33.7M | $-35.1M | ||
| Q3 25 | $-4.1M | $-232.1M | ||
| Q2 25 | $-72.6M | $-207.1M | ||
| Q1 25 | $-60.9M | $-182.5M | ||
| Q4 24 | $-60.2M | $-171.2M | ||
| Q3 24 | $-45.4M | $-154.5M | ||
| Q2 24 | $-35.5M | $-141.3M | ||
| Q1 24 | $-36.3M | $-122.3M |
总资产AQSTRENT
| Q4 25 | $160.4M | $231.0M | ||
| Q3 25 | $163.6M | $219.0M | ||
| Q2 25 | $93.7M | $245.3M | ||
| Q1 25 | $102.2M | $240.0M | ||
| Q4 24 | $101.4M | $251.6M | ||
| Q3 24 | $110.0M | $257.4M | ||
| Q2 24 | $117.6M | $278.4M | ||
| Q1 24 | $129.5M | $278.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.5M | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | $-8.6M | — |
| 自由现金流率自由现金流/营收 | -65.7% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | $-53.0M | — |
8季度趋势，按日历期对齐
经营现金流AQSTRENT
| Q4 25 | $-8.5M | $-1.4M | ||
| Q3 25 | $-12.6M | $-10.5M | ||
| Q2 25 | $-7.9M | $8.3M | ||
| Q1 25 | $-23.4M | $1.4M | ||
| Q4 24 | $-6.5M | $4.7M | ||
| Q3 24 | $-11.9M | $2.2M | ||
| Q2 24 | $-7.0M | $4.6M | ||
| Q1 24 | $-10.4M | $-8.0M |
自由现金流AQSTRENT
| Q4 25 | $-8.6M | — | ||
| Q3 25 | $-12.9M | — | ||
| Q2 25 | $-8.0M | — | ||
| Q1 25 | $-23.5M | — | ||
| Q4 24 | $-6.5M | — | ||
| Q3 24 | $-12.0M | — | ||
| Q2 24 | $-7.0M | — | ||
| Q1 24 | $-10.4M | — |
自由现金流率AQSTRENT
| Q4 25 | -65.7% | — | ||
| Q3 25 | -100.6% | — | ||
| Q2 25 | -80.2% | — | ||
| Q1 25 | -269.9% | — | ||
| Q4 24 | -54.8% | — | ||
| Q3 24 | -88.3% | — | ||
| Q2 24 | -35.0% | — | ||
| Q1 24 | -86.4% | — |
资本支出强度AQSTRENT
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率AQSTRENT
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
